Employees: 03 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2009-04-15 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: OSNY (95520), Val-d'Oise
SELEURL PHARMACIE GUIOT : revenue, balance sheet and financial ratios
SELEURL PHARMACIE GUIOT is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in OSNY (95520),
this company of category PME
shows in 2024 a revenue of 2.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELEURL PHARMACIE GUIOT (SIREN 511838161)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
2 916 026 €
2 736 728 €
N/C
N/C
N/C
N/C
1 739 709 €
1 663 735 €
Net income
94 632 €
114 744 €
100 527 €
135 013 €
103 725 €
103 386 €
91 429 €
93 375 €
91 439 €
EBITDA
N/C
119 323 €
120 599 €
N/C
N/C
N/C
N/C
131 011 €
134 087 €
Net margin
N/C
3.9%
3.7%
N/C
N/C
N/C
N/C
5.4%
5.5%
Revenue and income statement
In 2025, SELEURL PHARMACIE GUIOT generates positive net income of 95 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 91 k€ -> 95 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
94 632 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 2%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 89%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1.918%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
88.586%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
57.99
39.41
24.077
12.915
9.286
6.982
1.449
2.337
1.918
Financial autonomy
57.423
64.39
71.338
76.461
78.899
80.067
82.782
85.169
88.586
Repayment capacity
4.753
3.745
None
None
None
None
0.22
0.415
None
Cash flow / Revenue
5.638%
5.2%
None%
None%
None%
None%
3.347%
2.907%
None%
Sector positioning
Debt ratio
1.922025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Excellent
In 2025, the debt ratio of SELEURL PHARMACIE GUIOT (1.92) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
88.59%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Excellent+13 pts over 3 years
In 2025, the financial autonomy of SELEURL PHARMACIE GUIOT (88.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.41 years2024
2023
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Excellent
In 2024, the repayment capacity of SELEURL PHARMACIE GUIOT (0.41) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 430.97. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
208.099
192.888
175.14
171.269
204.89
245.254
239.905
314.022
430.969
Interest coverage
8.462
6.49
None
None
None
None
0.643
1.132
None
Sector positioning
Liquidity ratio
430.972025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent+9 pts over 3 years
In 2025, the liquidity ratio of SELEURL PHARMACIE GUIOT (430.97) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
1.13x2024
2023
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Average+9 pts over 2 years
In 2024, the interest coverage of SELEURL PHARMACIE GUIOT (1.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELEURL PHARMACIE GUIOT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
151 649 €
169 169 €
0 €
0 €
0 €
0 €
202 025 €
239 697 €
0 €
Inventory turnover (days)
33
33
0
0
0
0
30
32
0
Customer payment term (days)
3
3
0
0
0
0
2
2
0
Supplier payment term (days)
27
27
0
0
0
0
34
28
0
Positioning of SELEURL PHARMACIE GUIOT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELEURL PHARMACIE GUIOT is estimated at
1 503 240 €
(range 1 020 106€ - 2 358 791€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1020k€1503k€2358k€
1 503 240 €Range: 1 020 106€ - 2 358 791€
NAF 5 année 2025
Valuation method used
Net Income Multiple
94 632 €
×
15.9x
=1 503 241 €
Range: 1 020 106€ - 2 358 791€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELEURL PHARMACIE GUIOT with other companies in the same sector:
Frequently asked questions about SELEURL PHARMACIE GUIOT
What is the revenue of SELEURL PHARMACIE GUIOT ?
The revenue of SELEURL PHARMACIE GUIOT in 2024 is 2.9 M€.
Is SELEURL PHARMACIE GUIOT profitable?
Yes, SELEURL PHARMACIE GUIOT generated a net profit of 95 k€ in 2025.
Where is the headquarters of SELEURL PHARMACIE GUIOT ?
The headquarters of SELEURL PHARMACIE GUIOT is located in OSNY (95520), in the department Val-d'Oise.
Where to find the tax return of SELEURL PHARMACIE GUIOT ?
The tax return of SELEURL PHARMACIE GUIOT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELEURL PHARMACIE GUIOT operate?
SELEURL PHARMACIE GUIOT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart